BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 11732612)

  • 1. Structure-function relationship of serine protease-protein inhibitor interaction.
    Otlewski J; Jaskólski M; Buczek O; Cierpicki T; Czapińska H; Krowarsch D; Smalas AO; Stachowiak D; Szpineta A; Dadlez M
    Acta Biochim Pol; 2001; 48(2):419-28. PubMed ID: 11732612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamic criterion for the conformation of P1 residues of substrates and of inhibitors in complexes with serine proteinases.
    Qasim MA; Lu SM; Ding J; Bateman KS; James MN; Anderson S; Song J; Markley JL; Ganz PJ; Saunders CW; Laskowski M
    Biochemistry; 1999 Jun; 38(22):7142-50. PubMed ID: 10353824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of five bovine chymotrypsin complexes with P1 BPTI variants.
    Czapinska H; Helland R; Smalås AO; Otlewski J
    J Mol Biol; 2004 Dec; 344(4):1005-20. PubMed ID: 15544809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structures of the complexes between bovine beta-trypsin and ten P1 variants of BPTI.
    Helland R; Otlewski J; Sundheim O; Dadlez M; Smalås AO
    J Mol Biol; 1999 Apr; 287(5):923-42. PubMed ID: 10222201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interscaffolding additivity: binding of P1 variants of bovine pancreatic trypsin inhibitor to four serine proteases.
    Krowarsch D; Dadlez M; Buczek O; Krokoszynska I; Smalas AO; Otlewski J
    J Mol Biol; 1999 May; 289(1):175-86. PubMed ID: 10339415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitutions at the P(1) position in BPTI strongly affect the association energy with serine proteinases.
    Grzesiak A; Helland R; Smalås AO; Krowarsch D; Dadlez M; Otlewski J
    J Mol Biol; 2000 Aug; 301(1):205-17. PubMed ID: 10926503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of the canonical loop conformations in serine proteinases inhibitors and other proteins.
    Apostoluk W; Otlewski J
    Proteins; 1998 Sep; 32(4):459-74. PubMed ID: 9726416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Water molecules participate in proteinase-inhibitor interactions: crystal structures of Leu18, Ala18, and Gly18 variants of turkey ovomucoid inhibitor third domain complexed with Streptomyces griseus proteinase B.
    Huang K; Lu W; Anderson S; Laskowski M; James MN
    Protein Sci; 1995 Oct; 4(10):1985-97. PubMed ID: 8535235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of amino acid side-chains to S1 cavities of serine proteinases.
    Lu W; Apostol I; Qasim MA; Warne N; Wynn R; Zhang WL; Anderson S; Chiang YW; Ogin E; Rothberg I; Ryan K; Laskowski M
    J Mol Biol; 1997 Feb; 266(2):441-61. PubMed ID: 9047374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of an elastase-specific inhibitor elafin complexed with porcine pancreatic elastase determined at 1.9 A resolution.
    Tsunemi M; Matsuura Y; Sakakibara S; Katsube Y
    Biochemistry; 1996 Sep; 35(36):11570-6. PubMed ID: 8794736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phage display selection of P1 mutants of BPTI directed against five different serine proteinases.
    Kiczak L; Koscielska K; Otlewski J; Czerwinski M; Dadlez M
    Biol Chem; 1999 Jan; 380(1):101-5. PubMed ID: 10064144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin.
    Krokoszynska I; Dadlez M; Otlewski J
    J Mol Biol; 1998 Jan; 275(3):503-13. PubMed ID: 9466927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interscaffolding additivity. Association of P1 variants of eglin c and of turkey ovomucoid third domain with serine proteinases.
    Qasim MA; Ganz PJ; Saunders CW; Bateman KS; James MN; Laskowski M
    Biochemistry; 1997 Feb; 36(7):1598-607. PubMed ID: 9048543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of the bovine alpha-chymotrypsin:Kunitz inhibitor complex. An example of multiple protein:protein recognition sites.
    Capasso C; Rizzi M; Menegatti E; Ascenzi P; Bolognesi M
    J Mol Recognit; 1997; 10(1):26-35. PubMed ID: 9179777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural consequences of accommodation of four non-cognate amino acid residues in the S1 pocket of bovine trypsin and chymotrypsin.
    Helland R; Czapinska H; Leiros I; Olufsen M; Otlewski J; Smalås AO
    J Mol Biol; 2003 Oct; 333(4):845-61. PubMed ID: 14568540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
    Zhang E; St Charles R; Tulinsky A
    J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicted three-dimensional structural models of venom serine protease inhibitors and their interactions with trypsin and chymotrypsin.
    Azim MK; Grossmann JG; Zaidi ZH
    J Nat Toxins; 1999 Oct; 8(3):363-84. PubMed ID: 10591040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of peptide bonds to inhibitor-protease binding: crystal structures of the turkey ovomucoid third domain backbone variants OMTKY3-Pro18I and OMTKY3-psi[COO]-Leu18I in complex with Streptomyces griseus proteinase B (SGPB) and the structure of the free inhibitor, OMTKY-3-psi[CH2NH2+]-Asp19I.
    Bateman KS; Huang K; Anderson S; Lu W; Qasim MA; Laskowski M; James MN
    J Mol Biol; 2001 Jan; 305(4):839-49. PubMed ID: 11162096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.